Works by Guo, Xiaohui


Results: 277
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2182, doi. 10.1111/dom.14803
    By:
    • Yuan, Xiaoyong;
    • Guo, Xiaohui;
    • Zhang, Junqing;
    • Dong, Xiaolin;
    • Lu, Yibing;
    • Pang, Wuyan;
    • Gu, Shenghong;
    • Niemoeller, Elisabeth;
    • Ping, Lin;
    • Nian, Gaowei;
    • Souhami, Elisabeth
    Publication type:
    Article
    45
    46
    47
    48
    49
    50